Xenon Pharmaceuticals (XENE) Misses Q1 EPS by 2c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q1 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $601 thousand versus the consensus estimate of $3.3 million.

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c